InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: cdiddy01 post# 94002

Monday, 03/04/2019 5:43:40 PM

Monday, March 04, 2019 5:43:40 PM

Post# of 108192
The Aduro trials were further along, as I believe they missed a primary end point on a phase 2 trial. Berlin said one of the reasons Amgen said they terminated was because of the high risk, which essentially means the initial data pointed to lower probability that the platform will be successful compared to Amgen's original underwriting of the program pre data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News